SPHK2 and diabetes mellitus: In contrast, SphK2 can be pathogenic, as systemic loss of Sphk2 ameliorates diabetes by preventing pancreatic β-cell death and improves insulin sensitivity in aged mice by promoting lipolysis in adipose tissue (15, 16).